Torrent Pharmaceuticals Limited FII & DII Activity
5-Day Flow Trend
| Date | FII Net (₹ Cr) | DII Net (₹ Cr) |
|---|---|---|
| 2026-09-04 | −3111.94 | +8930.12 |
| 2026-09-03 | −2345.87 | +4977.46 |
| 2026-09-02 | +6688.37 | +2812.98 |
| 2026-09-01 | −7985.88 | +4588.88 |
| 2026-08-31 | −7985.88 | +4588.88 |
Today's Institutional Flow
On 4 September 2026, foreign institutional investors (FIIs) posted a net cash outflow of ₹‑3,111.94 Cr from Indian equities, while domestic institutional investors (DIIs) injected a net ₹ 8,930.12 Cr of cash. The contrasting positions highlight a pronounced shift in sentiment, with FIIs reducing exposure as DIIs deepen their stakes. This divergence suggests that domestic players are more optimistic about the near‑term outlook for listed companies, including those in the pharmaceutical space.
Trend vs 5‑Day Average
The day’s FII outflow exceeds the five‑day average net cash outflow of ₹‑3,333.81 Cr, indicating a slightly milder retreat than the recent trend. Conversely, DII inflows of ₹ 8,930.12 Cr are marginally below their five‑day average of ₹ 4,430.43 Cr, showing that today’s domestic buying pace is still robust but not as aggressive as the past week’s average.
F&O Positioning Data
FIIs built a net long futures‑and‑options (F&O) exposure of ₹ 374,795 Cr, reflecting confidence in directional bets despite the cash outflow. Their index futures positioning stands at a long‑to‑short ratio of 1.2, signifying a modest net long bias across equity indices.
Healthcare Sector Flow
In the broader healthcare sector, FIIs have been net sellers over the past week while DIIs continue to accumulate, reinforcing a bullish domestic narrative for pharma stocks such as Torrent Pharmaceuticals Limited (TORNTPHARM).
Market-wide FII/DII data — same for all F&O stocks. Date: 2026-09-04